Stockreport

Structure Therapeutics (GPCR) Rallying on Obesity Drug Data [Yahoo! Finance]

Structure Therapeutics Inc.  (GPCR) 
PDF study as well as top-line data from a capsule-to-tablet PK study on its obesity candidate, GSBR-1290, on Jun 3. Both studies met their primary and secondary endpoints. [Read more]